Wilmington, Delaware, United States, June 09, 2023 (GLOBE NEWSWIRE) -- The global intravascular ultrasound [IVUS] devices market is anticipated to grow at a 5.9% CAGR from 2023 to 2031. A market ...
MIAMI BEACH, FL—Intravascular imaging deserves a larger role in peripheral vascular interventions, according to a newly released consensus opinion of leaders spanning the many specialties involved in ...
The Eagle Eye Platinum digital IVUS catheter is the #1 choice of physicians for intravascular imaging (in the US). As a unique plug-and-play intravascular imaging catheter it is designed for ease of ...
Compared with angiography alone, adding IVUS imaging to femoropopliteal artery interventions with drug-coated balloons (DCBs) results in less binary restenosis at 1 year, according to results from a ...
ORLANDO, FL – A strategy of using intravascular ultrasound (IVUS) to guide the implantation of an everolimus-eluting stent (Xience Prime, Abbott Vascular) for long lesions resulted in a significant ...
WILMINGTON, DE / ACCESSWIRE / October 13, 2022 / Transparency Market Research Inc. - The products and solutions offered by players in the global intravascular ultrasound (IVUS) devices market are used ...
Independent analysis includes Centers for Medicare & Medicaid Services (CMS) data from over 700,000 peripheral arterial and peripheral venous intervention patients Data demonstrate a 32% reduction in ...
Sudden cardiac death and myocardial infarction are often caused by rupture of a lipid-rich fibroatheroma. Intravascular ultrasonography (IVUS) has been used extensively to detect and characterize ...
The first multimodality coronary imaging catheter has recently received 510(k) clearance from the FDA. The LipiScan IVUS Coronary Imaging System (InfraReDx) device is the result of 10 years of ...
Please provide your email address to receive an email when new articles are posted on . Although initially described in the early 1970s, technological advancements during the past 2 decades have ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and IVUS solutions, today announced the results of a new large-scale real-world analysis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results